Blue Earth Therapeutics Unveils Promising Phase 1 Results for Prostate Cancer Treatment Blue Earth Therapeutics presents significant findings from its Phase 1 clinical trial of Lutetium (177Lu) rhPSMA-10.1 Injection, showcasing hope for prostate cancer patients.

Blue Earth Therapeutics Unveils Promising Phase 1 Results for Prostate Cancer Treatment #United_Kingdom #Oxford #Prostate_Cancer #Blue_Earth #Lutetium